Sam Williams

CEO, director and investor in the biotech sector

[Sam Williams @biotech_CEO]

@TurpinCharmaine I have your father's complete fighting record, as written out by his then trainer, I believe. Let me know if interested.

[Sam Williams @biotech_CEO]

@Dan_Mahony I will settle for 'seductive' 😬 https://t.co/T5GmGbAmPt

[Daniel Mahony @Dan_Mahony]

Remember @biotech_CEO , they thought the company @modernbio was interesting - I think you will have to settle for inspirational https://t.co/yoWzpkvuZa

[Sam Williams @biotech_CEO]

@_rjw @JohnCFierce @lisamjarvis Financial community also responsible, overlooking the clearly flawed P2 data and selective disclosure by Co

[Sam Williams @biotech_CEO]

@lnternetHeroes like it

[Scientific American @sciam]

Why a journal just banned scientists from using p-values in their studies: http://t.co/NKDmUsoPaB #science #research

[Sam Williams @biotech_CEO]

@portefeuillefun @DrugDiscoverer that's almost 30% out! But not bad I guess given I haven't been following this one before now. Thanks!

[Sam Williams @biotech_CEO]

@DrugDiscoverer @AndyBiotech hah. I'm just chancing my arm. Someone's gotta do it

[Sam Williams @biotech_CEO]

@AndyBiotech @DrugDiscoverer yep exactly right. Good ACR a given these days. Question is opp infections. And structural data. All in the P3

[Sam Williams @biotech_CEO]

@DrugDiscoverer @AndyBiotech $GLPG stock'll be up, regardless. 12%?

[Sam Williams @biotech_CEO]

@DrugDiscoverer @AndyBiotech @DrugDiscoverer @AndyBiotech Humira monoTx ACR 20 50 70 = 53% 35% 18% so actually pretty good by comparison

[Sam Williams @biotech_CEO]

@DrugDiscoverer @AndyBiotech so only stat significant at ACR20 50 and 70 at the highest doses. Not sure it's ground-breaking.

[Dr. Kevin Campbell, MD, FACC, MBA @DrKevinCampbell]

A drug rep showed up in my office today with this. Really?

[Sam Williams @biotech_CEO]

@DrugDiscoverer it wasn't me!

[Sam Williams @biotech_CEO]

@DrugDiscoverer That's a good question. It's all in the mix with OX-1...!

[Phil Holliger @PhilHolliger]

New paper from my group at Nature AOP: http://t.co/FYVXr5xmcL. XNAs can do catalysis: XNAzymes cleave RNA, ligate RNA and ligate XNAs.

[George Freeman FRSA MP @MPGeorgeFreeman]

UK Life Sciences Biomedical Catalyst funding cited as key to R&D alliance between Modern Biosciences Plc & Janssen Biotech @biotech_CEO

[Sam Williams @biotech_CEO]

@DrugDiscoverer Possibly, Lisa, as the JAKs simply haven't delivered, at least on safety. Must be some nervous cos developing JAKs out there

[Sam Williams @biotech_CEO]

@JohnCFierce @DamianFierce @biotech_CEO great piece @DamianFierce

[John Carroll @JohnCendpts]

J&J bets up to $277M on a prospect from its R&D farm system
by @DamianFierce @biotech_CEO http://t.co/kpyiGcsIiZ

[Sam Williams @biotech_CEO]

@PDRennert @JohnCFierce Undisclosed, I'm afraid. However, I can say that we have a unique effect, acting directly on inflammation and bone